Sponsor or institution
Clinical trials and research at Galderma R&D
As of November 12, 2026, Find a Trial lists 10 clinical trials run by Galderma R&D that are recruiting, at sites in 5 countries (most in United States (7), China (3), Germany (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 1New in 30 days
- 5Countries
Newest trials
All recruiting trials (10)
-
Midface contour and volume in Chinese adults treated with Sculptra™ over long term
This study tests whether Sculptra™ used in standard practice can safely improve midface fullness over about two years in Chinese adults who have previously received the treatment.
-
Improve profile of the jawline using Restylane Shaype
This study tests whether Restylane Shaype can improve jawline definition in adults of Chinese origin who want treatment for their jawline.
-
Nemolizumab vs placebo in Chinese teens and adults with moderate-to-severe atopic dermatitis
This study tests whether Nemolizumab can help moderate-to-severe atopic dermatitis in Chinese participants aged 12 and up, compared with a placebo.
-
Nemolizumab for infants with moderate-to-severe atopic dermatitis
This study tests whether nemolizumab can be safely given to infants aged 6 to under 24 months to help manage moderate-to-severe eczema when topical treatments alone aren’t enough.
-
Retreatment with Restylane Lyft with Lidocaine for chin augmentation
This study tests whether retreating the chin with Restylane Lyft with Lidocaine is safe when done about 3 months after a prior treatment.
-
Skin changes after biostimulator (Sculptra) treatment seen with non-invasive imaging
We will try Sculptra injections in women aged 45–65 with moderate-to-severe cheek wrinkles to see how their skin changes over three treatments using non-invasive imaging.
-
PLLA (Sculptra) effects on cheek skin across menopausal stages
This study will test whether PLLA (Sculptra) injections change skin protein levels and improve cheek wrinkles in menopausal women.
-
Nemolizumab for adults with systemic sclerosis
This trial will test whether nemolizumab can reduce skin thickness in adults with systemic sclerosis over a 52-week treatment period.
-
Using nemolizumab (Nemluvio) to treat moderate-to-severe prurigo nodularis in adults
This project tries nemolizumab (Nemluvio) in adults with moderate-to-severe prurigo nodularis to see if it reduces itching and symptoms by six months.
-
Nemolizumab for moderate-to-severe atopic dermatitis in adolescents and adults
This will try nemolizumab in adolescents and adults with moderate-to-severe atopic dermatitis to see if it improves symptoms and patient-reported outcomes over six months.
Quick answers
How many clinical trials run by Galderma R&D are recruiting right now?
10, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (7 trials), China (3 trials), Germany (2 trials), United Kingdom (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.